News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
Content Sharing
<H Shrs>HSI Fades 479 Pts at Midday as 'New Consumption F4' Wane; Travel Platform Stocks Subtract
The HSI faded 479 points or 2% to 23,231 at midday. The HSCEI shed 181 points or 2.1% to 8,412. The HSTECH lost 124 points or 2.4% to 5,090. Total half-day turnover of the market a...
Reset
Send
The window will close in 5 seconds
<H Shrs>HSI Fades 479 Pts at Midday as 'New Consumption F4' Wane; Travel Platform Stocks Subtract
Close
Recommend
2
Positive
4
Negative
6
 
 

The HSI faded 479 points or 2% to 23,231 at midday. The HSCEI shed 181 points or 2.1% to 8,412. The HSTECH lost 124 points or 2.4% to 5,090. Total half-day turnover of the market amounted to $123.32 billion.

Consumers declined. JIUMAOJIU (09922.HK)  0.000 (0.000%)    Short selling $2.47M; Ratio 8.917%   and HENGAN INT'L (01044.HK)  0.000 (0.000%)    Short selling $12.21M; Ratio 21.440%   cascaded 3.6%, while MAOYAN ENT (01896.HK)  +0.140 (+1.864%)    Short selling $1.85M; Ratio 6.583%   and ALI PICTURES (01060.HK)  -0.040 (-4.301%)    Short selling $34.28M; Ratio 8.201%   shrank 4.5% and 5.2%. XIABUXIABU (00520.HK)  -0.020 (-2.899%)   plummeted 9.2%. For “new consumption F4”, MIXUE GROUP (02097.HK)  +20.200 (+4.091%)   eroded 4%, while POP MART (09992.HK)  -9.000 (-3.620%)    Short selling $1.44B; Ratio 14.727%   stumbled 5.3%. CEB BANK (06818.HK)  +0.060 (+1.550%)    Short selling $12.62M; Ratio 7.121%   descended 6.4%, while MAO GEPING (01318.HK)  +0.300 (+0.301%)    Short selling $46.71M; Ratio 9.662%   plunged 7.6%.

Pharma CANSINOBIO (06185.HK)  +1.500 (+4.478%)    Short selling $4.87M; Ratio 4.476%   , WUXI BIO (02269.HK)  0.000 (0.000%)    Short selling $239.39M; Ratio 31.150%   , GENSCRIPT BIO (01548.HK)  -0.120 (-0.821%)    Short selling $40.87M; Ratio 15.838%   , PHARMARON (03759.HK)  +0.100 (+0.658%)    Short selling $2.37M; Ratio 4.728%   , SSY GROUP (02005.HK)  +0.040 (+1.498%)    Short selling $5.50M; Ratio 12.880%   and AKESO (09926.HK)  -0.750 (-0.815%)    Short selling $42.95M; Ratio 5.840%   cratered 4-4.6%, while LUYE PHARMA (02186.HK)  +0.060 (+1.840%)    Short selling $20.72M; Ratio 7.792%   and CSPC PHARMA (01093.HK)  +0.010 (+0.131%)    Short selling $246.37M; Ratio 14.362%   waned 5.3% and 6%.

The market was concerned about JD-SW (09618.HK)  +0.900 (+0.722%)    Short selling $683.61M; Ratio 30.043%   entering the travel industry, with JD-SW and MEITUAN-W (03690.HK)  +0.300 (+0.234%)    Short selling $737.04M; Ratio 12.603%   slipping 3.8% and 3.1%. TRIP.COM-S (09961.HK)  +1.800 (+0.405%)    Short selling $259.43M; Ratio 15.844%   and TONGCHENGTRAVEL (00780.HK)  -0.570 (-2.815%)    Short selling $119.75M; Ratio 21.097%   dived 4% and 9.3%.

For other techs, BABA-W (09988.HK)  +1.700 (+1.545%)    Short selling $3.21B; Ratio 26.960%   , TENCENT (00700.HK)  +7.500 (+1.506%)    Short selling $2.17B; Ratio 20.960%   , NEW ORIENTAL-S (09901.HK)  +0.850 (+2.368%)    Short selling $49.93M; Ratio 26.296%   and BIDU-SW (09888.HK)  +0.750 (+0.913%)    Short selling $144.12M; Ratio 17.482%   slumped 1.7-2.2%, while NTES-S (09999.HK)  +0.800 (+0.394%)    Short selling $305.77M; Ratio 19.232%   and SMIC (00981.HK)  +0.650 (+1.673%)    Short selling $245.09M; Ratio 9.594%   ebbed 0.5% and 0.8%. KUAISHOU-W (01024.HK)  +0.150 (+0.266%)    Short selling $236.62M; Ratio 19.267%   and BILIBILI-W (09626.HK)  +2.100 (+1.360%)    Short selling $93.62M; Ratio 16.329%   receded 3.3% and 3.4%.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2025-06-20 16:25.)

AASTOCKS Financial News
Website: www.aastocks.com

Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.